Quest PharmaTech Balance Sheet

Financials in millions CAD. Fiscal year is February - January.

Millions CAD. Fiscal year is Feb - Jan.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jan '26 Jan 31, 2026	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022
Cash & Equivalents	0.01	0.21	0.72	0.37	0.26
Cash & Short-Term Investments	0.01	0.21	0.72	0.37	0.26
Cash Growth	-93.00%	-71.39%	91.36%	41.73%	32.76%
Other Receivables	-	-	0.1	0.22	0
Total Trade Receivables	-	-	0.1	0.22	0
Other Current Assets	0.02	0.02	0.02	0.03	0.02
Total Current Assets	0.03	0.23	0.84	0.62	0.29
Net Property, Plant & Equipment	-	-	-	0	0.02
Long-Term Investments	27.72	22.33	23.63	26.17	90.71
Other Long-Term Assets	27.73	22.34	23.65	26.19	90.75
Total Assets	27.75	22.56	24.48	26.8	91.03
Accounts Payable	0.33	0.17	0.32	0.11	0.11
Short-Term Debt	1	1	1	1	0.5
Current Portion of Leases	-	-	-	-	0.01
Total Current Liabilities	1.33	1.17	1.32	1.11	0.62
Total Liabilities	1.33	1.17	1.32	1.11	0.62
Common Stock	30.74	30.74	30.74	30.74	30.62
Additional Paid-in Capital	11.77	11.69	11.6	11.13	11.06
Accumulated Other Comprehensive Income	-0.2	-0.15	-0.11	-0.11	-0.05
Retained Earnings	-15.88	-20.88	-19.08	-16.06	48.78
Shareholders' Equity	26.43	21.4	23.15	25.7	90.41
Total Liabilities & Equity	27.75	22.56	24.48	26.8	91.03
Total Debt	1	1	1	1	0.51
Net Cash (Debt)	-0.99	-0.79	-0.28	-0.63	-0.25
Net Cash Per Share	-0.01	-0.01	-0.00	-0.00	-0.00
Book Value	26.43	21.4	23.15	25.7	90.41
Book Value Per Share	0.16	0.13	0.14	0.15	0.54
Tangible Book Value	26.43	21.4	23.15	25.7	90.41
Tangible Book Value Per Share	0.16	0.13	0.14	0.15	0.54